The second PCR step uses the Illumina Nextera dual index primers for PCR amplification, allowing up to 96 samples to be pooled onto one Illumina MiSeq run. With the Illumina sequencing both strands of ...

MiSeq reagents enable up to 15 Gb of output with 25 million sequencing reads and 2 × 300 bp read lengths. Illumina MiSeq Workflow Overview Play Video credit: Illumina ...

The MiSeq desktop sequencer allows access tomore focused applications such as targeted gene sequencing, metagenomics, small genome sequencing, targeted gene expression, amplicon sequencing, and HLA ...

The Bristol Genomics Facility has the capacity to run both high output and low output next generation sequencing experiments. The Illumina NextSeq500 system is perfect for the sequencing of whole ...

Illumina Inc. (NASDAQ:ILMN), a leading provider of next-generation sequencing (NGS ... instruments such as the recently announced MiSeq i100 series. These platforms, along with associated ...

Next-generation sequencing (NGS) has moved away from expensive ... NGS Benchtop Systems at Illumina, discusses how the MiSeq i100 Series of sequencers was designed to meet the needs of experienced NGS ...

The MiSeq desktop sequencer offers low throughput flowcells and long read lengths. It is best for small whole-genome sequencing, targeted gene sequencing, metagenomics, and CRISPR validation. The ...

Illumina Inc (NASDAQ:ILMN)., a leading player in the genomic sequencing industry, finds itself at a critical juncture as it navigates a shifting competitive landscape and global economic challenges.

San Diego-based Illumina, a global leader in genomic sequencing technology, unveiled its latest machines that could make analyzing genetics cheaper, more efficient and more accessible to researchers.

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies ... Illumina recently launched the MiSeq i100 and MiSeq i100 Plus Systems, two powerful, compact ...

The Genomics Core offers a wide range of genomic and DNA/RNA services. We operate the Illumina NovaSeq X Plus, NextSeq 550, and MiSeq platforms for all Next Generation Sequencing and offer an ...

Illumina Inc. (NASDAQ:ILMN), a leading provider of next-generation sequencing (NGS) technology with annual revenue of $4.37 billion, finds itself at a critical juncture as it navigates a shifting ...